Mixture toxicity of the antiviral drug Tamiflu® (oseltamivir ethylester) and its active metabolite oseltamivir acid

This publication has 26 references indexed in Scilit:

• Oseltamivir Carboxylate, the Active Metabolite of Oseltamivir Phosphate (Tamiflu), Detected in Sewage Discharge and River Water in Japan
  Environmental Health Perspectives, 2010
• Extending the environmental risk assessment for oseltamivir (Tamiflu®) under pandemic use conditions to the coastal marine compartment
  Environment International, 2009
• Detection of the Antiviral Drug Oseltamivir in Aquatic Environments
  PLOS ONE, 2009
• Meeting Report: Risk Assessment of Tamiflu Use Under Pandemic Conditions
  Environmental Health Perspectives, 2008
• A review of independent action compared to concentration addition as reference models for mixtures of compounds with different molecular target sites
  Environmental Toxicology and Chemistry, 2008
• Monitoring of the ecotoxicological hazard potential by polar organic micropollutants in sewage treatment plants and surface waters using a mode-of-action based test battery
  Journal of Environmental Monitoring, 2008
• Toxic equivalent concentrations (TEQs) for baseline toxicity and specific modes of action as a tool to improve interpretation of ecotoxicity testing of environmental samples
  Journal of Environmental Monitoring, 2008
• Peer Reviewed: Internal Exposure: Linking Bioavailability to Effects
  Environmental Science & Technology, 2004
• Clinical Pharmacokinetics of the Prodrug Oseltamivir and its Active Metabolite Ro 64-0802
  Clinical Pharmacokinetics, 1999
• Solid Phase Microextraction as a Tool To Determine Membrane/Water Partition Coefficients and Bioavailable Concentrations in in Vitro Systems
  Chemical Research in Toxicology, 1997